A new study suggests that COVID-19 specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the novel coronavirus — a potentially critical feature of an effective vaccine.
A new study suggests that COVID-19 specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the novel coronavirus — a potentially critical feature of an effective vaccine.